Cáncer de mama tras radioterapia supradiafragmática.
Palabras clave:
Cáncer de mama, poster, seram, radioterapia supradiafragmática, SDIResumen
Objetivos Docentes
El pronóstico de los pacientes con enfermedad de Hodgkin ha mejorado significativamente en los últimos 50 años gracias al empleo de radioterapia y quimioterapia.
Sin embrago, el seguimiento a largo plazo de los supervivientes ha demostrado un incremento en la aparición de segundas neoplasias.
Revisión del tema
El cáncer de mama que se produce en las mujeres supervivientes de la enfermedad de Hodgkin se debe fundamentalmente al empleo de radioterapia supradiafragmática (SDI) que recibieron como parte del tratamiento para superar la enfermedad primaria.
Descargas
Citas
Travis LB, Hill DA, Dores GM, Gospodarowicz M, van Leeuwen FE,Holowaty E, Glimelius B, Andersson M, Wiklund T, Lynch CF,van’t Veer MB, Glimelius I, Storm H, Pukkala E, Stovall M, Curtis R,Boice Jr JD, Gilbert E (2003) Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA 2003; 290: 465–75.
Aisenberg AC, Finkelstein DM, Doppke KP, Koerner FC, Boivin J-F, Willett CG (1997) High risk of breast carcinoma after irradiation of young women with Hodgkin’s disease. Cancer. 1997; 79: 1203–10.
Protocolo de seguimiento en el Hospital Universitario de Cruces para la detección precoz del cáncer de mama para pacientes supervivientes de la enfermedad de Hodgkin. Octubre 2012.
SwerdlowA, Cooke R, Bates A, Cunningham D, Falk SJ, Gilson D, Hancock BW, Harris SJ, Horwich A, Hoskin PJ, Linch DC, Lister TA, Lucraft HH, Radford JA, Stevens AM, Syndikus I, Williams MV. Breast Cancer Risk after supradiaphragmatic radiotherapy for Hodgkin´s Lymphoma in England and Wales: A National Cohort Study. J Clin Oncol. 2012; 30:2745-52.
Crump M. Toward risk-based breast cancer screening and prevention strategies for survivors of Hodgkin´s lymphima: One step closer? J Clin Oncol. 2012; 30:2712-14. Horwich A, Swerdlow AJ. Second primary breasr cancer after Hodgkin´s disease. British Journal of Cancer 2004; 90:294-8.
Allen SD, Wallis MG, Cooke R, Swerdlow AJ. Radiologic features of breast cancer after mantle radiation therapy for Hodgkin disease: A study of 230 cases. Radiology 2014; 272: 73-8.
Tieu MT, Cigsar C, Ahmed S, NG A, Diller L, Millar BA, Crystal P, Hodgson DC. Breast cancer detection among young survivors of pediatric Hodgkin lymphoma with screening magnetic resonance imaging. Cancer 2014; 120:2507-13.
Saslow D, Boetes C, Burke W, Harms S, Leach MO, Lehman CD, Morris E, Pisano E, Schnall M, Sener S, Smith RA, Warner E, Yaffe M, Andrews KS, Russell CA. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 2007; 57:75-89.
Mainiero MB, Lourenco A, Mahoney MC, Newell MS, Bailey L, Barke LD, D´Orsi C, Harver JA, Hayes MK et al. ,American College of Radiology ACR Appropiateness criteria for breast cancer screening 2012.
De Bruin ML, Sparidans J, van´t Veer MB, Noordijk EM, Louwman MWJ, Zijlstra JM, van der Berg H, Russell NS, Broeks A, Baaijens MHA, Aleman BMP, van Leeuwen FE. Breast cancer risk in females survivors of Hodgkin´s lymphoma: Lower risk after smaller radiation volumes. J Clin Oncol. 2009; 27:4239-46.
Tardivon AA, Garnier ML, Beaudré A, Girinsky T. Breast carcinoma in women previously treated for Hodgkin´s disease: clinical and mammographic findings. Eur Radiol. 1999;9:1666-71.
Ng AK, Garber JE, Diller LR, Birdwell RL, Feng Y, Neuberg DS, Silver B, Fisher DC, Marcus KJ, Mauch PM. Prospective study of the efficacy of breast magnetic resonance imaging and mammographic screening in survivors of Hodgkin lymphoma. J Clin Oncol. 2013. http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2012.46.5732.
